News Search

A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.

Demographically younger nations have a higher aging burden than previously thought and need new policies to prevent large numbers of people from leaving the workforce due to ill health.

Columbia geneticist Wendy Chung reflects on the progress made in cancer genetics and discusses the next frontier of using genetic information to design personalized cancer prevention strategies.